{"@id":"https://bioecon.ru/technology/oral-integrin-allosteric-modulators/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://cn.bioecon.ru/technology/oral-integrin-allosteric-modulators/","json":"https://cn.bioecon.ru/api/v1/technology/oral-integrin-allosteric-modulators/index.json"},"id":"oral-integrin-allosteric-modulators","industries":["pharma","biomanufacturing"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/quantec-ltd/","https://bioecon.ru/companies/astrazeneca/","https://bioecon.ru/companies/shin-etsu-chemical/","https://bioecon.ru/companies/gsk/","https://bioecon.ru/companies/atomwise/","https://bioecon.ru/companies/newlimit/","https://bioecon.ru/companies/ph-albio/","https://bioecon.ru/companies/21st-bio/","https://bioecon.ru/companies/cellmeat/","https://bioecon.ru/companies/kilimorgano/"]},"maturity":7,"name":"口服变构型整合素小分子调节剂","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"整合素分子绞链区变构对接筛选"},{"n":2,"title":"生理流动剪切应力细胞黏附阻断"},{"n":3,"title":"口服肠道黏膜靶向药代药效优化"},{"n":4,"title":"炎症性肠病肠道黏膜深层愈合确证"}],"summary":"通过口服给药精准结合异二聚体整合素（如α4β7、αvβ6）变构调控口袋的小分子调节剂，将其永久锁定于弯曲低亲和力构象，阻断致病性白细胞向肠道或纤维化组织的异常渗出。","url":"/technology/oral-integrin-allosteric-modulators/","verified":"2026-11-22"}